Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Transforming the workers’ compensation pharmacy and ancillary benefits management experience

Powered by state-of-the-art technology
Supported by human-centered service
Informed by industry expertise
Inspired by a commitment to care
women with a migraine post image
blog

Novel Migraine Agents: What is Their Place in Injured Worker Therapy?

While these drugs offer relief for migraine sufferers, what are the efficacy and cost considerations for injured workers?
Read More
rxinformer

Ask a Clinician: What Do I need to Know About DME Trends?

Healthesystems clinicians tackle questions about Durable Medical Equipment (DME).
Read More
MAC Monitor and magazine cover graphic
INDUSTRY SURVEY

2024 Industry Survey Report

This sixth annual survey report highlights the top challenges and priorities of 500 industry professionals.
Read More

Featured Videos

Personalize my experience

Make selections below to see articles and information related to your role and interests.
  • I am a

  • I'm interested in

WCRI Reports on Interstate Variation Trends in Drug Payments

Data from 28 states years found that NSAIDs and dermatological agents are seeing growth in spending.

Jul 2020

NCCI Issues Q2 Economics Briefing

An exploration of job loss due to the COVID-19 pandemic.

Jun 2020

States Limit COVID-19 Liability

Could Arkansas and Louisiana start a trend?

Jun 2020

WCIRB Examines COVID-19’s Impact on California Comp

WCIRB analyzes historic data on economic cycles.

Jun 2020


COVID-19: Hydroxychloroquine and Remdesivir Updates

The malaria drug loses an EUA for COVID-19, while the FDA warns of drug interactions that can reduce antiviral effectiveness.

Jun 2020

Growing Pains: The Shift from Opioids to Other Pain Therapies

With opioid utilization decreasing, what concerns do other pain therapies pose?

Jun 2020

WCRI Publishes Medical Price Index

With data from 36 states across 12 years, this report highlights the differences in prices paid for medical services across the nation.

Jun 2020

Washington Issues Guidelines on COVID-19 Masks for Workers

Occupations are divided into risk categories where each category must utilize appropriate face coverings, masks, or respirators.

Jun 2020

Employee Stress and Mental Health When Returning to Work

The National Safety Council discusses managing employee anxiety stemming from COVID-19 when returning to work.

Jun 2020

CWCI Explores Integration of COVID-19 Claims

COVID-19 claim data was gathered in a survey to understand impacts to comp.

May 2020

FDA Nixes Certain COVID-19 Antibody Tests

This announcement impacts 31 antibody tests.

May 2020

Rising to the Challenge: Meeting Adversity During Complex Times

A message from our Chief Executive Officer

Spring/Summer 2020

Saliva Test with At-Home Collection Authorized

Saliva samples collected at-home must be sent to the designated lab.

May 2020

2020 Workers’ Comp Industry Insights Survey & Infographic

Results, insights, and various stakeholder perspectives on important industry issues

Spring/Summer 2020

Growing Pains: The Shift from Opioids to Other Pain Therapies

With opioid utilization decreasing, what concerns do other pain therapies pose?

Spring/Summer 2020

FDA Approves Elyxyb Oral Solution for Migraines

Elyxyb (celecoxib) is an NSAID for the acute treatment of migraine with or without aura.

May 2020

Live Better, Heal Better: Employee Wellness in Workers' Comp

How comorbidities, fatigue, and mental health impact claims management.

May 2020

Live Better, Heal Better: Employee Wellness in Workers’ Comp

Strategies for addressing comorbidities, fatigue, and mental health to positively impact claims

Spring/Summer 2020

Texas Reminds Providers Certain Exams Must Be Done in Person

Maximum medical improvement (MME) and impairment rating (IR) evaluations cannot be done remotely.

May 2020

Remdesivir a Potential Treatment for COVID-19?

The FDA allows emergency use in response to positive trials, but more research is needed.

May 2020

A New Routine: The Growth of Complex Claims and How to Manage Them

Potential causes and solutions for increasing claims complexity

Spring/Summer 2020

State of the States

A roundup of regulatory activity around the country

Spring/Summer 2020

IQVIA Reports on Healthcare Shifts in the COVID-19 Era

A new study explores patients’ use of health services, the impact on medicine use, research activity, and more.

May 2020

California Executive Order Greatly Expands COVID-19 Presumption

Many states expanded workers’ comp for COVID-19, but California casts a wider net.

May 2020

By the Numbers: Covid-19 Edition

A collection of facts and figures surrounding the COVID-19 pandemic

Spring/Summer 2020

NCCI Publishes COVID-19 Resource Center

Lists of compiled information on telehealth, public notices, and more.

Apr 2020

Update on Antibody Testing

Testing for COVID-19 antibodies is not a conclusive test for infection.

Apr 2020

1 2 3 4 5 12 13 14 15 16 18 19 20 21 22
lockenvelopephone-handsetmagnifiermenuarrow-rightcross-circle